The first trial among more than 2,000 in a class-action lawsuit accusing several manufacturers of testosterone treatments of not adequately warning users of the potential for cardiovascular side effects with use of the hormone therapy, is scheduled to begin June 5, according to the Cook County Record. The class action lawsuits date back to 2014 and name drug companies such as AbbVie, Besins, Eli Lily and GlaxoSmithKline. The lawsuits were consolidated in the U.S. District Court for Northern Illinois in Chicago. Plaintiffs allege the testosterone replacement therapies were promoted for off-label uses, including diabetes, AIDS, cancer, depression and anxiety. Specifically, ... Read More
Righting Injustice is published by the Beasley Allen Law Firm. If you are interested in a free legal consultation, please take a few moments to fill out the contact form with as many details as possible. The more information you provide us, the better we can evaluate your claim.